Laura K Shawver

Title: A Spotlight on Inventor Laura K. Shawver

Introduction

Laura K. Shawver, an innovative inventor based in Alameda, CA, has made significant contributions to the field of cancer therapy. With two patents to her name, she has been dedicated to developing novel approaches that enhance the efficacy of anti-neoplastic drugs in treating cancer.

Latest Patents

Among her most notable patents is one focused on the "Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy." This invention explores synergistic combinations of ligand-mimicking agents that specifically target the c-erbB-2 protein, along with anti-neoplastic agents like cisplatin. The methodology involves administering these combinations in therapeutically effective amounts to treat patients suspected of having cancer or tumor cells. The combinations aim to induce phosphorylation of the c-erbB-2 protein or facilitate its internalization, thereby inhibiting the growth of tumor cells, specifically breast and ovarian cancer.

Career Highlights

Laura K. Shawver is currently associated with Berlex Laboratories, Inc., where she continues her groundbreaking work in cancer research. Her commitment to finding effective cancer therapies underscores her significant role in the medical and scientific community.

Collaborations

Throughout her career, Shawver has collaborated with notable colleagues, including John W. Brandis and Elaina Mann, reflecting her ability to work within a team of dedicated professionals striving towards common goals in cancer therapeutics.

Conclusion

Laura K. Shawver's innovative spirit and her commitment to enhancing cancer treatment through patentable research contribute greatly to the ongoing fight against cancer. Her work not only exemplifies the importance of innovation in medicine but also offers hope to many who suffer from this challenging disease.